chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Minor Sore Injection Site only post first shot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Minor Sore Injection Site only post first shot) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced VACCINATION SITE PAIN (Minor Sore Injection Site only post first shot). On 30-Jan-2021, VACCINATION SITE PAIN (Minor Sore Injection Site only post first shot) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications was reported Treatment information was not provided
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Product availability issue
Clinical narrative: had his first shot on 08FEB2021 and is about to go beyond the 42 days; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT AVAILABILITY ISSUE (had his first shot on 08FEB2021 and is about to go beyond the 42 days) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT AVAILABILITY ISSUE (had his first shot on 08FEB2021 and is about to go beyond the 42 days). At the time of the report, PRODUCT AVAILABILITY ISSUE (had his first shot on 08FEB2021 and is about to go beyond the 42 days) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  He was scheduled for second one on 07-Mar-2021 but something occurred in the system that it was not Moderna that they were giving at the site. No treatment information was provided.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Epistaxis
Clinical narrative: severe nose bleed; This spontaneous case was reported by a pharmacist and describes the occurrence of EPISTAXIS (severe nose bleed) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced EPISTAXIS (severe nose bleed). At the time of the report, EPISTAXIS (severe nose bleed) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications included unspecified medications but not related to blood thinners. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Cold sweat, Feeling abnormal, Feeling hot, Headache, Nausea
Clinical narrative: almost passed out 2X within a 20 minute period; didn't feel good; hot; clammy; nauseous; headache; A Spontaneous report was received from a Consumer concerning a female patient of 34 years who received a dose of Moderna's COVID-19 vaccine (mRNA-1273) and experienced almost passed out twice,  feeling hot, feeling abnormal, nausea, cold sweat, headache, .  The patient's medical history was not provided.  No relevant concomitant medications were reported.  On 17 Mar 2021, the patient received her dose of mRNA-1273 (lot/batch: 038A21A) on her right arm for prophylaxis of COVID-19 infection.   On 18 Mar 2021, the patient reports, since morning she did not feel good, was hot, nauseous, clammy, had a headache. when she was at the store, she almost  passed out  twice within a 20 minute period.   Laboratory details were not provided.  Treatment details were not provided.  Action taken with mRNA-1273 in response to the events was not reported.  On date of this report, the outcome of the events of patient experiencing almost passed out, feeling abnormal, feeling hot, nausea, cold sweat, headache were not recovered/ not resolved.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Presyncope
Clinical narrative: almost passed out 2X within a 20 minute period; didn't feel good; hot; clammy; nauseous; headache; A Spontaneous report was received from a Consumer concerning a female patient of 34 years who received a dose of Moderna's COVID-19 vaccine (mRNA-1273) and experienced almost passed out twice,  feeling hot, feeling abnormal, nausea, cold sweat, headache, .  The patient's medical history was not provided.  No relevant concomitant medications were reported.  On 17 Mar 2021, the patient received her dose of mRNA-1273 (lot/batch: 038A21A) on her right arm for prophylaxis of COVID-19 infection.   On 18 Mar 2021, the patient reports, since morning she did not feel good, was hot, nauseous, clammy, had a headache. when she was at the store, she almost  passed out  twice within a 20 minute period.   Laboratory details were not provided.  Treatment details were not provided.  Action taken with mRNA-1273 in response to the events was not reported.  On date of this report, the outcome of the events of patient experiencing almost passed out, feeling abnormal, feeling hot, nausea, cold sweat, headache were not recovered/ not resolved.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: tiredness; This spontaneous case was reported by a physician and describes the occurrence of FATIGUE (tiredness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FATIGUE (tiredness). At the time of the report, FATIGUE (tiredness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  No treatment information was provided.   This case was linked to MOD-2021-047907 (Patient Link).
Age: 49.0
Sex: U
Vaccine: COVID19
Symptoms: Body temperature, Headache, Musculoskeletal stiffness, Neck pain, Pyrexia
Clinical narrative: 36 hours of headache and neck pain; neck stiffness; headache; 36 hours of headache and neck pain; a fever of 101.5-101.6; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (36 hours of headache and neck pain), MUSCULOSKELETAL STIFFNESS (neck stiffness), HEADACHE (headache), HEADACHE (36 hours of headache and neck pain) and PYREXIA (a fever of 101.5-101.6) in a 49-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced NECK PAIN (36 hours of headache and neck pain), MUSCULOSKELETAL STIFFNESS (neck stiffness), HEADACHE (headache), HEADACHE (36 hours of headache and neck pain) and PYREXIA (a fever of 101.5-101.6). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form and IBUPROFEN ongoing since an unknown date at a dose of 1 dosage form. On 14-Mar-2021, PYREXIA (a fever of 101.5-101.6) had resolved. At the time of the report, NECK PAIN (36 hours of headache and neck pain), MUSCULOSKELETAL STIFFNESS (neck stiffness), HEADACHE (headache) and HEADACHE (36 hours of headache and neck pain) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Mar-2021, Body temperature: 101.5-101.6. (High) 101.5-101.6..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant was provided.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pain, Pain in extremity, Pyrexia
Clinical narrative: sore arm; achyness; fever; exhaustion; headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), PAIN (achyness), PYREXIA (fever), FATIGUE (exhaustion) and HEADACHE (headache) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in March 2020. Concomitant products included LISINOPRIL for an unknown indication.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced PAIN IN EXTREMITY (sore arm), PAIN (achyness), PYREXIA (fever), FATIGUE (exhaustion) and HEADACHE (headache). The patient was treated with IBUPROFEN for Adverse event, at a dose of 1 dosage form. In March 2021, PAIN IN EXTREMITY (sore arm), PAIN (achyness), PYREXIA (fever), FATIGUE (exhaustion) and HEADACHE (headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose, Bone pain, Chills, Dizziness, Feeling abnormal
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm ), FEELING ABNORMAL (Felt Horrible), SOMNOLENCE (Slept all day), TREMOR (Shaking) and DIZZINESS (Dizziness) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes, Liver cirrhosis, Overweight, Anemic and Osteoarthritis.    On 26-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm ). On 27-Feb-2021, the patient experienced FEELING ABNORMAL (Felt Horrible), TREMOR (Shaking), DIZZINESS (Dizziness), OROPHARYNGEAL PAIN (Terrible Sore throat), RHINORRHOEA (Runny Nose), BONE PAIN (bones Ache), CHILLS (Chills), HEADACHE (Headache), MYALGIA (Muscle Ache), NAUSEA (Nausea) and PYREXIA (Fever 102.3 F). On 28-Feb-2021, the patient experienced SOMNOLENCE (Slept all day). On 27-Feb-2021, PAIN IN EXTREMITY (Sore arm ) had resolved. On 02-Mar-2021, FEELING ABNORMAL (Felt Horrible), SOMNOLENCE (Slept all day), TREMOR (Shaking), DIZZINESS (Dizziness), OROPHARYNGEAL PAIN (Terrible Sore throat), RHINORRHOEA (Runny Nose), BONE PAIN (bones Ache), CHILLS (Chills), HEADACHE (Headache), MYALGIA (Muscle Ache), NAUSEA (Nausea) and PYREXIA (Fever 102.3 F) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Feb-2021, Blood glucose: normal normal.         No concomitant medications were reported.   No treatment information was provided.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Nausea, Oropharyngeal pain, Pain in extremity
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm ), FEELING ABNORMAL (Felt Horrible), SOMNOLENCE (Slept all day), TREMOR (Shaking) and DIZZINESS (Dizziness) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes, Liver cirrhosis, Overweight, Anemic and Osteoarthritis.    On 26-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm ). On 27-Feb-2021, the patient experienced FEELING ABNORMAL (Felt Horrible), TREMOR (Shaking), DIZZINESS (Dizziness), OROPHARYNGEAL PAIN (Terrible Sore throat), RHINORRHOEA (Runny Nose), BONE PAIN (bones Ache), CHILLS (Chills), HEADACHE (Headache), MYALGIA (Muscle Ache), NAUSEA (Nausea) and PYREXIA (Fever 102.3 F). On 28-Feb-2021, the patient experienced SOMNOLENCE (Slept all day). On 27-Feb-2021, PAIN IN EXTREMITY (Sore arm ) had resolved. On 02-Mar-2021, FEELING ABNORMAL (Felt Horrible), SOMNOLENCE (Slept all day), TREMOR (Shaking), DIZZINESS (Dizziness), OROPHARYNGEAL PAIN (Terrible Sore throat), RHINORRHOEA (Runny Nose), BONE PAIN (bones Ache), CHILLS (Chills), HEADACHE (Headache), MYALGIA (Muscle Ache), NAUSEA (Nausea) and PYREXIA (Fever 102.3 F) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Feb-2021, Blood glucose: normal normal.         No concomitant medications were reported.   No treatment information was provided.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Rhinorrhoea, Somnolence, Tremor
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm ), FEELING ABNORMAL (Felt Horrible), SOMNOLENCE (Slept all day), TREMOR (Shaking) and DIZZINESS (Dizziness) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes, Liver cirrhosis, Overweight, Anemic and Osteoarthritis.    On 26-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm ). On 27-Feb-2021, the patient experienced FEELING ABNORMAL (Felt Horrible), TREMOR (Shaking), DIZZINESS (Dizziness), OROPHARYNGEAL PAIN (Terrible Sore throat), RHINORRHOEA (Runny Nose), BONE PAIN (bones Ache), CHILLS (Chills), HEADACHE (Headache), MYALGIA (Muscle Ache), NAUSEA (Nausea) and PYREXIA (Fever 102.3 F). On 28-Feb-2021, the patient experienced SOMNOLENCE (Slept all day). On 27-Feb-2021, PAIN IN EXTREMITY (Sore arm ) had resolved. On 02-Mar-2021, FEELING ABNORMAL (Felt Horrible), SOMNOLENCE (Slept all day), TREMOR (Shaking), DIZZINESS (Dizziness), OROPHARYNGEAL PAIN (Terrible Sore throat), RHINORRHOEA (Runny Nose), BONE PAIN (bones Ache), CHILLS (Chills), HEADACHE (Headache), MYALGIA (Muscle Ache), NAUSEA (Nausea) and PYREXIA (Fever 102.3 F) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Feb-2021, Blood glucose: normal normal.         No concomitant medications were reported.   No treatment information was provided.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site pruritus, Vaccination site rash
Clinical narrative: Injection site itchy rash which is 3 inches high by 2 inches wide, in shape of triangle and widening out; Injection site itchy rash which is 3 inches high by 2 inches wide, in shape of triangle and widening out; Arm was a little sore, no big deal; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm was a little sore, no big deal), VACCINATION SITE PRURITUS (Injection site itchy rash which is 3 inches high by 2 inches wide, in shape of triangle and widening out) and VACCINATION SITE RASH (Injection site itchy rash which is 3 inches high by 2 inches wide, in shape of triangle and widening out) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Mar-2021 at 9:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm was a little sore, no big deal). On 16-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (Injection site itchy rash which is 3 inches high by 2 inches wide, in shape of triangle and widening out) and VACCINATION SITE RASH (Injection site itchy rash which is 3 inches high by 2 inches wide, in shape of triangle and widening out). At the time of the report, PAIN IN EXTREMITY (Arm was a little sore, no big deal), VACCINATION SITE PRURITUS (Injection site itchy rash which is 3 inches high by 2 inches wide, in shape of triangle and widening out) and VACCINATION SITE RASH (Injection site itchy rash which is 3 inches high by 2 inches wide, in shape of triangle and widening out) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Constant headache since vaccination; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Constant headache since vaccination) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Migraine.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Constant headache since vaccination). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at an unspecified dose and frequency and IBUPROFEN for Headache, at an unspecified dose and frequency. At the time of the report, HEADACHE (Constant headache since vaccination) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Dry mouth, Pain in extremity, Rhinorrhoea, Vaccination site pruritus, Vaccination site rash
Clinical narrative: Extremely dry mouth making it difficult to eat; itchy at the injection site; rash at the injection site; swelling at the injection site; very runny nose; very sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (very sore arm), RHINORRHOEA (very runny nose), DRY MOUTH (Extremely dry mouth making it difficult to eat), VACCINATION SITE PRURITUS (itchy at the injection site) and VACCINATION SITE RASH (rash at the injection site) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced PAIN IN EXTREMITY (very sore arm). On 13-Mar-2021, the patient experienced RHINORRHOEA (very runny nose). On 16-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (itchy at the injection site), VACCINATION SITE RASH (rash at the injection site) and VACCINATION SITE SWELLING (swelling at the injection site). On 17-Mar-2021, the patient experienced DRY MOUTH (Extremely dry mouth making it difficult to eat). On 10-Mar-2021, PAIN IN EXTREMITY (very sore arm) had resolved. At the time of the report, RHINORRHOEA (very runny nose), DRY MOUTH (Extremely dry mouth making it difficult to eat), VACCINATION SITE PRURITUS (itchy at the injection site), VACCINATION SITE RASH (rash at the injection site) and VACCINATION SITE SWELLING (swelling at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   No treatment was administered by patient for events.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: Extremely dry mouth making it difficult to eat; itchy at the injection site; rash at the injection site; swelling at the injection site; very runny nose; very sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (very sore arm), RHINORRHOEA (very runny nose), DRY MOUTH (Extremely dry mouth making it difficult to eat), VACCINATION SITE PRURITUS (itchy at the injection site) and VACCINATION SITE RASH (rash at the injection site) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced PAIN IN EXTREMITY (very sore arm). On 13-Mar-2021, the patient experienced RHINORRHOEA (very runny nose). On 16-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (itchy at the injection site), VACCINATION SITE RASH (rash at the injection site) and VACCINATION SITE SWELLING (swelling at the injection site). On 17-Mar-2021, the patient experienced DRY MOUTH (Extremely dry mouth making it difficult to eat). On 10-Mar-2021, PAIN IN EXTREMITY (very sore arm) had resolved. At the time of the report, RHINORRHOEA (very runny nose), DRY MOUTH (Extremely dry mouth making it difficult to eat), VACCINATION SITE PRURITUS (itchy at the injection site), VACCINATION SITE RASH (rash at the injection site) and VACCINATION SITE SWELLING (swelling at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   No treatment was administered by patient for events.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Adverse reaction, Musculoskeletal stiffness, Neck pain
Clinical narrative: adverse reaction for 9 days; Stiff neck which was extremely painful and was on entire right side all the way down to foot; Stiff neck which was extremely painful and was on entire right side all the way down to foot; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (Stiff neck which was extremely painful and was on entire right side all the way down to foot), NECK PAIN (Stiff neck which was extremely painful and was on entire right side all the way down to foot) and ADVERSE REACTION (adverse reaction for 9 days) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     Concomitant products included LIRAGLUTIDE (VICTOZA), GABAPENTIN, LEVOTHYROXINE, LISINOPRIL, TOLTERODINE, SIMVASTATIN, OMEPRAZOLE, FENOFIBRATE, METOPROLOL and VITAMINS NOS for an unknown indication.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (Stiff neck which was extremely painful and was on entire right side all the way down to foot) and NECK PAIN (Stiff neck which was extremely painful and was on entire right side all the way down to foot). On an unknown date, the patient experienced ADVERSE REACTION (adverse reaction for 9 days). The patient was treated with ACETAMINOPHEN for Stiff neck and Neck pain, at an unspecified dose and frequency. At the time of the report, MUSCULOSKELETAL STIFFNESS (Stiff neck which was extremely painful and was on entire right side all the way down to foot), NECK PAIN (Stiff neck which was extremely painful and was on entire right side all the way down to foot) and ADVERSE REACTION (adverse reaction for 9 days) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No medical history information was provided.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Vertigo
Clinical narrative: Vertigo; Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Vertigo) and DIZZINESS (Dizziness) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included LISINOPRIL and ATORVASTATIN CALCIUM (LIPITOR) for an unknown indication.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced VERTIGO (Vertigo) and DIZZINESS (Dizziness). At the time of the report, VERTIGO (Vertigo) and DIZZINESS (Dizziness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment was administered by patient for events.  No medical history information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Rash erythematous
Clinical narrative: redness on her torso, as well as the front and back of her arms and legs described as red rash; tired; This spontaneous case was reported by a physician and describes the occurrence of RASH ERYTHEMATOUS (redness on her torso, as well as the front and back of her arms and legs described as red rash) and FATIGUE (tired) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced FATIGUE (tired). On 16-Mar-2021, the patient experienced RASH ERYTHEMATOUS (redness on her torso, as well as the front and back of her arms and legs described as red rash). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Red rash, at an unspecified dose and frequency. At the time of the report, RASH ERYTHEMATOUS (redness on her torso, as well as the front and back of her arms and legs described as red rash) was resolving and FATIGUE (tired) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.    Most recent FOLLOW-UP information incorporated above includes: On 17-Mar-2021: Information regarding patient, suspect drug and events was received and case became valid.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Coronavirus test, Depressed mood, Product dose omission issue
Clinical narrative: está muy angustiada / is very distressed; se colocó la primera dosis de la vacuna Moderna el 04Feb2021 y no consigue cita para la; This spontaneous case was reported by a consumer and describes the occurrence of DEPRESSED MOOD (está muy angustiada / is very distressed) and PRODUCT DOSE OMISSION ISSUE (se colocó la primera dosis de la vacuna Moderna el 04Feb2021 y no consigue cita para la) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported. ).    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced DEPRESSED MOOD (está muy angustiada / is very distressed) and PRODUCT DOSE OMISSION ISSUE (se colocó la primera dosis de la vacuna Moderna el 04Feb2021 y no consigue cita para la). On 17-Mar-2021, PRODUCT DOSE OMISSION ISSUE (se colocó la primera dosis de la vacuna Moderna el 04Feb2021 y no consigue cita para la) had resolved. At the time of the report, DEPRESSED MOOD (está muy angustiada / is very distressed) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Coronavirus test: negative (Negative) three tests were negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.   Reporter did not allow further contact; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Insomnia, Nausea, Vaccination site bruising, Vaccination site pain
Clinical narrative: Bruise at the injection site; Left arm started hurting and aching again at injection site; Trouble sleeping last night; Blue blood clot on left hand/ Bump on hand; Sore left arm; Stomach occasionally jumps; Feeling "queasy" occasionally; A spontaneous report was received from a 80-year-old, female, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced sore left arm, feeling queasy, stomach occasionally jumps, a blue blood clot and a bump on hand, hurting and aching at injection site, bruise at the injection site, and trouble sleeping last night.  The patient's medical history included hypothyroidism. Products known to have been used by the patient, within two weeks prior to the events, included Levothyroxine sodium.  On 04 Mar 2021, prior to onset of events, the patient received her first of two planned doses of mRNA-1273 (Lot number: 040A21A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 05 Mar 2021, one day post vaccination, the patient experienced sore left arm that eventually went away, felt queasy and her stomach occasionally jumped. On 06 Mar 2021, the patient noticed a blue blood clot on her left hand and stated that it was like a bump. On 10 Mar 2021 patient has seen the nurse for  bump on her hand and was told likely from strain on a tendon or blood vessel. she was told to ice the bump. On 15 Mar 2021, she had trouble sleeping. On 16 Mar 2021, she had hurting and aching at the site of injection and bruise at injection site.  Action taken with mRNA-1273 in response to events was not provided.  The outcome of the event, sore left arm was resolved on an unspecified date in Mar2021 and outcome of the events feeling queasy, stomach occasionally jumps, a blue blood clot, a bump on hand, hurting and aching at injection site, bruise at the injection site and trouble sleeping last night was unknown at the time of this report.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site reaction
Clinical narrative: Bruise at the injection site; Left arm started hurting and aching again at injection site; Trouble sleeping last night; Blue blood clot on left hand/ Bump on hand; Sore left arm; Stomach occasionally jumps; Feeling "queasy" occasionally; A spontaneous report was received from a 80-year-old, female, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced sore left arm, feeling queasy, stomach occasionally jumps, a blue blood clot and a bump on hand, hurting and aching at injection site, bruise at the injection site, and trouble sleeping last night.  The patient's medical history included hypothyroidism. Products known to have been used by the patient, within two weeks prior to the events, included Levothyroxine sodium.  On 04 Mar 2021, prior to onset of events, the patient received her first of two planned doses of mRNA-1273 (Lot number: 040A21A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 05 Mar 2021, one day post vaccination, the patient experienced sore left arm that eventually went away, felt queasy and her stomach occasionally jumped. On 06 Mar 2021, the patient noticed a blue blood clot on her left hand and stated that it was like a bump. On 10 Mar 2021 patient has seen the nurse for  bump on her hand and was told likely from strain on a tendon or blood vessel. she was told to ice the bump. On 15 Mar 2021, she had trouble sleeping. On 16 Mar 2021, she had hurting and aching at the site of injection and bruise at injection site.  Action taken with mRNA-1273 in response to events was not provided.  The outcome of the event, sore left arm was resolved on an unspecified date in Mar2021 and outcome of the events feeling queasy, stomach occasionally jumps, a blue blood clot, a bump on hand, hurting and aching at injection site, bruise at the injection site and trouble sleeping last night was unknown at the time of this report.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Vaccination site pain
Clinical narrative: Headache; pain in the arm at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) and VACCINATION SITE PAIN (pain in the arm at the injection site) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced HEADACHE (Headache) and VACCINATION SITE PAIN (pain in the arm at the injection site). At the time of the report, HEADACHE (Headache) and VACCINATION SITE PAIN (pain in the arm at the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: Outcome of events updated.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Nausea, Vomiting
Clinical narrative: Severe Diarrhea; vomiting, could not keep anything down; nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA ( Severe Diarrhea), VOMITING (vomiting, could not keep anything down) and NAUSEA (nausea) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced DIARRHOEA ( Severe Diarrhea), VOMITING (vomiting, could not keep anything down) and NAUSEA (nausea). At the time of the report, DIARRHOEA ( Severe Diarrhea), VOMITING (vomiting, could not keep anything down) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   No treatment information was provided.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Tremor
Clinical narrative: Light achiness; hand shaking; A spontaneous report was received from consumer (patient) concerning a 47-years-old,female patient who received Moderna's COVID-19 Vaccine (mRNA-1273) and had hand shaking  and light achiness (pain).  No medical history was provided. No concomitant medications were provided.  On 16 Mar 2021, the patient received their first of two planned doses of mRNA-1273 (Lot number: not provided), intramuscularly in left arm for prophylaxis of COVID-19 infection.  On 16 Mar 2021, the patient had light achiness and hands shaking  (medically significant) after receiving first dose.  The treatment information was not provided.  Action taken with mRNA-1273 in response to the events was unknown.  The outcome of the events of hand shaking and light achiness (pain) was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain
Clinical narrative: Experiencng redness around the injection site; Experienced some pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Experienced some pain at the injection site) and VACCINATION SITE ERYTHEMA (Experiencng redness around the injection site) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 12-Mar-2021, the patient experienced VACCINATION SITE PAIN (Experienced some pain at the injection site). On 16-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (Experiencng redness around the injection site). On 16-Mar-2021, VACCINATION SITE PAIN (Experienced some pain at the injection site) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (Experiencng redness around the injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant product use was reported.  Treatment for the events included application of ice onto the injection site.   Reporter did not allow further contact
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Adverse reaction, Hypokinesia
Clinical narrative: all the possible side effects being reported; Patient was really bad, she couldn't even move; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (all the possible side effects being reported) and HYPOKINESIA (Patient was really bad, she couldn't even move) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced ADVERSE REACTION (all the possible side effects being reported) and HYPOKINESIA (Patient was really bad, she couldn't even move). The patient was treated with NAPROXEN SODIUM (ALEVE) for Adverse event, at an unspecified dose and frequency. At the time of the report, ADVERSE REACTION (all the possible side effects being reported) and HYPOKINESIA (Patient was really bad, she couldn't even move) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: No significant information was received.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Blood urine present, Diarrhoea, Fatigue, Pollakiuria
Clinical narrative: Injection site swelling; Pass some blood through his urine; Severe lower back pain; Having to urinate a lot; Loose bowels; Very tired; His injection site is red; His injection site hurts; Swelling in his right arm that's about 1.5 inch x 1.5 inch at the injection site; This spontaneous case was reported by an other health care professional and describes the occurrence of BLOOD URINE PRESENT (Pass some blood through his urine), BACK PAIN (Severe lower back pain), POLLAKIURIA (Having to urinate a lot), DIARRHOEA (Loose bowels) and FATIGUE (Very tired) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Arthritis.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced BLOOD URINE PRESENT (Pass some blood through his urine), BACK PAIN (Severe lower back pain), POLLAKIURIA (Having to urinate a lot), DIARRHOEA (Loose bowels), FATIGUE (Very tired), VACCINATION SITE ERYTHEMA (His injection site is red), VACCINATION SITE PAIN (His injection site hurts) and VACCINATION SITE SWELLING (Swelling in his right arm that's about 1.5 inch x 1.5 inch at the injection site). On 25-Mar-2021, the patient experienced VACCINATION SITE SWELLING (Injection site swelling). The patient was treated with IBUPROFEN ongoing since an unknown date for Pain, at a dose of UNK dosage form. On 19-Mar-2021, VACCINATION SITE SWELLING (Swelling in his right arm that's about 1.5 inch x 1.5 inch at the injection site) had resolved. At the time of the report, BLOOD URINE PRESENT (Pass some blood through his urine), BACK PAIN (Severe lower back pain), POLLAKIURIA (Having to urinate a lot), DIARRHOEA (Loose bowels), FATIGUE (Very tired), VACCINATION SITE ERYTHEMA (His injection site is red) and VACCINATION SITE PAIN (His injection site hurts) outcome was unknown and VACCINATION SITE SWELLING (Injection site swelling) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 25-Mar-2021: Reporter information updated, event added.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site swelling
Clinical narrative: Injection site swelling; Pass some blood through his urine; Severe lower back pain; Having to urinate a lot; Loose bowels; Very tired; His injection site is red; His injection site hurts; Swelling in his right arm that's about 1.5 inch x 1.5 inch at the injection site; This spontaneous case was reported by an other health care professional and describes the occurrence of BLOOD URINE PRESENT (Pass some blood through his urine), BACK PAIN (Severe lower back pain), POLLAKIURIA (Having to urinate a lot), DIARRHOEA (Loose bowels) and FATIGUE (Very tired) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Arthritis.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced BLOOD URINE PRESENT (Pass some blood through his urine), BACK PAIN (Severe lower back pain), POLLAKIURIA (Having to urinate a lot), DIARRHOEA (Loose bowels), FATIGUE (Very tired), VACCINATION SITE ERYTHEMA (His injection site is red), VACCINATION SITE PAIN (His injection site hurts) and VACCINATION SITE SWELLING (Swelling in his right arm that's about 1.5 inch x 1.5 inch at the injection site). On 25-Mar-2021, the patient experienced VACCINATION SITE SWELLING (Injection site swelling). The patient was treated with IBUPROFEN ongoing since an unknown date for Pain, at a dose of UNK dosage form. On 19-Mar-2021, VACCINATION SITE SWELLING (Swelling in his right arm that's about 1.5 inch x 1.5 inch at the injection site) had resolved. At the time of the report, BLOOD URINE PRESENT (Pass some blood through his urine), BACK PAIN (Severe lower back pain), POLLAKIURIA (Having to urinate a lot), DIARRHOEA (Loose bowels), FATIGUE (Very tired), VACCINATION SITE ERYTHEMA (His injection site is red) and VACCINATION SITE PAIN (His injection site hurts) outcome was unknown and VACCINATION SITE SWELLING (Injection site swelling) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 25-Mar-2021: Reporter information updated, event added.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Malaise, Pain, Pyrexia
Clinical narrative: Felt out of sorts; Achy; Fatigued; Fever of 101.7F; Chills; Soreness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Felt out of sorts), PAIN (Achy), FATIGUE (Fatigued), PYREXIA (Fever of 101.7F) and CHILLS (Chills) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 11-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced MALAISE (Felt out of sorts), PAIN (Achy), FATIGUE (Fatigued), PYREXIA (Fever of 101.7F), CHILLS (Chills) and VACCINATION SITE PAIN (Soreness at injection site). At the time of the report, MALAISE (Felt out of sorts), PAIN (Achy), FATIGUE (Fatigued), PYREXIA (Fever of 101.7F), CHILLS (Chills) and VACCINATION SITE PAIN (Soreness at injection site) outcome was unknown.            No concomitant medications were reported.   No treatment information was provided.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Felt out of sorts; Achy; Fatigued; Fever of 101.7F; Chills; Soreness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Felt out of sorts), PAIN (Achy), FATIGUE (Fatigued), PYREXIA (Fever of 101.7F) and CHILLS (Chills) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 11-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced MALAISE (Felt out of sorts), PAIN (Achy), FATIGUE (Fatigued), PYREXIA (Fever of 101.7F), CHILLS (Chills) and VACCINATION SITE PAIN (Soreness at injection site). At the time of the report, MALAISE (Felt out of sorts), PAIN (Achy), FATIGUE (Fatigued), PYREXIA (Fever of 101.7F), CHILLS (Chills) and VACCINATION SITE PAIN (Soreness at injection site) outcome was unknown.            No concomitant medications were reported.   No treatment information was provided.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Chills
Clinical narrative: Chills; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced CHILLS (Chills). On 16-Mar-2021, CHILLS (Chills) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient is concomitantly taking medications for high blood pressure.  Patient did not administer any corrective for event.